Investors

Corporate Profile

Founded in 2006, Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye.

The foundation of Ocular Therapeutix's pipeline is based on its proprietary, bioresorbable hydrogel technology that uses polyethylene glycol, or PEG, as a key component. The most advanced product candidate, currently in Phase 3 clinical development, is a drug-eluting intracanalicular depot containing the ste... More >>

Stock QuoteMore >>
OCUL (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$6.38
Change (%) Stock is Down 0.5 (0.00%)
Volume193,670
Data as of 08/24/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
 
Investor EventsMore >>
DateTitle
10/13/16
OIS@AAO
LocationHyatt Regency
Chicago, IL
Industry EventsMore >>
There are currently no events scheduled.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Ocular Therapeutix, Inc. posts new information to the site.
Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.